Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The survival rates of hair grafts are similar regardless of how they are trimmed.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Different scalp imaging methods are important for studying hair and scalp health and require more volunteers for better evaluation.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

Vitamin A affects hair loss and immune response in alopecia areata.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

PRP therapy increases hair density for androgenetic alopecia.

Minoxidil effectively treats hair loss, with better results in women.

PRP injections can help increase hair density and thickness in men with hair loss.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

The document suggests recognizing "trichiatrists" as doctors specializing in hair and scalp health, using evidence-based treatments.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Impaired autophagy may cause hair loss by triggering early catagen.

Body hairs can be used in forensic science and toxicology like scalp hair.